Published in Biochim Biophys Acta on February 03, 1992
Engineering of PDMS surfaces for use in microsystems for capture and isolation of complex and biomedically important proteins: epidermal growth factor receptor as a model system. Lab Chip (2008) 0.81
Physicochemical characterization of the cytoplasmic domain of the epidermal growth factor receptor and evidence for conformational changes associated with its activation by ammonium sulphate. Biochem J (1995) 0.78
A highly efficient peptide substrate for EGFR activates the kinase by inducing aggregation. Biochem J (2013) 0.77
Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation. J Biol Chem (1984) 1.80
Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. J Biol Chem (1985) 1.80
Combined modality therapy for primary CNS lymphoma. J Clin Oncol (1992) 1.53
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med (1996) 1.46
Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol (2001) 1.37
Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer (1994) 1.21
Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem (1998) 1.17
Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin Exp Allergy (2010) 1.14
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem (1996) 1.12
Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol Endocrinol (2000) 1.10
ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesis. J Biol Chem (2000) 1.06
Pediatric desmoid tumor: retrospective analysis of 63 cases. J Clin Oncol (1995) 1.06
Integrin-mediated migration of murine B82L fibroblasts is dependent on the expression of an intact epidermal growth factor receptor. J Biol Chem (1999) 1.06
Epidermal growth factor and its receptor. Mol Cell Endocrinol (1987) 1.04
Phosphorylation of protein 4.1 on tyrosine-418 modulates its function in vitro. Proc Natl Acad Sci U S A (1991) 1.00
Kinetics of phosphorylation of Na+/K(+)-ATPase by protein kinase C. Biochim Biophys Acta (1990) 1.00
Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins. J Biol Chem (1992) 1.00
Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status. J Biol Chem (2000) 1.00
A three-step purification procedure for protein kinase C: characterization of the purified enzyme. Anal Biochem (1987) 1.00
Platelet-derived growth factor-stimulated migration of murine fibroblasts is associated with epidermal growth factor receptor expression and tyrosine phosphorylation. J Biol Chem (2000) 0.99
Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase. J Biol Chem (1999) 0.98
Nativity, complications, and pathology are determinants of surgical results for gastric cancer. Cancer (1994) 0.97
Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma. Clin Exp Allergy (2013) 0.96
Regional distribution of cytosolic and particulate 5alpha-dihydroprogesterone 3alpha-hydroxysteroid oxidoreductases in female rat brain. J Steroid Biochem Mol Biol (1997) 0.96
The juxtamembrane, cytosolic region of the epidermal growth factor receptor is involved in association with alpha-subunit of Gs. J Biol Chem (1997) 0.95
Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region. Arch Biochem Biophys (1999) 0.93
Modulation of epidermal growth factor receptor interaction with the detergent-insoluble cytoskeleton and its effects on receptor tyrosine kinase activity. Endocrinology (1995) 0.91
Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with the detergent-insoluble cellular cytoskeleton: analysis of intact and carboxy-terminally truncated receptors. Endocrinology (1993) 0.89
Regulation of the epidermal growth factor receptor by phosphorylation. J Cell Biochem (1985) 0.87
Calcium and phosphatidylserine stimulate the self-association of conventional protein kinase C isoforms. Biochemistry (1999) 0.87
Protection of mice from endotoxic death by 2-methylthio-ATP. Proc Natl Acad Sci U S A (1994) 0.86
Calmodulin N-methyltransferase. Kinetics, mechanism, and inhibitors. J Biol Chem (1996) 0.86
Interleukin 5 signals through Shc and Grb2 in human eosinophils. Am J Respir Cell Mol Biol (1998) 0.85
Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts. J Biol Chem (1999) 0.84
Granulocyte macrophage colony-stimulating factor and interleukin-5 activate STAT5 and induce CIS1 mRNA in human peripheral blood eosinophils. Am J Respir Cell Mol Biol (2001) 0.82
The juxtamembrane region of the epidermal growth factor receptor is required for phosphorylation of Galpha(s). Arch Biochem Biophys (2000) 0.82
Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain. Oncogene (2009) 0.82
Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy. Proc Assoc Am Physicians (1996) 0.81
The impact of measurement error on the comparison of two treatments using a responder analysis. Stat Med (1999) 0.81
Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins. Biochem J (1992) 0.81
Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes. Biochem J (1991) 0.81
CD14(+) cells are necessary for increased survival of eosinophils in response to lipopolysaccharide. Am J Respir Cell Mol Biol (2000) 0.81
Reversibility of the epidermal growth factor receptor self-phosphorylation reaction. Evidence for formation of a high energy phosphotyrosine bond. J Biol Chem (1989) 0.81
Regulatory features of the epidermal growth factor receptor. J Cell Physiol Suppl (1987) 0.80
Nucleotide receptor P2RX7 stimulation enhances LPS-induced interferon-β production in murine macrophages. J Leukoc Biol (2013) 0.80
Partial characterization of the microsomal and solubilized hypothalamic progesterone 5 alpha-reductase. J Steroid Biochem (1984) 0.79
Down-regulation of epidermal growth factor receptor-dependent signaling by Porphyromonas gingivalis lipopolysaccharide in life-expanded human gingival fibroblasts. J Periodontal Res (2008) 0.79
Growth hormone attenuation of epidermal growth factor-induced mitogenesis. J Cell Physiol (1997) 0.78
Activation of protein kinase C by selective binding of arginine-rich polypeptides. J Biol Chem (1993) 0.78
High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery. Bone Marrow Transplant (1996) 0.78
Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal. Infect Immun (1998) 0.78
Kinetic analysis of protein kinase C: product and dead-end inhibition studies using ADP, poly(L-lysine), nonhydrolyzable ATP analogues, and diadenosine oligophosphates. Biochemistry (1991) 0.78
The kinetic mechanism of the anterior pituitary progesterone 5 alpha-reductase. J Steroid Biochem (1986) 0.77
Pituitary progesterone 5 alpha-reductase: solubilization and partial characterization. J Steroid Biochem (1985) 0.77
IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol (1996) 0.77
Insights into modulation of (and by) growth hormone signaling. J Lab Clin Med (2000) 0.76
Tolbutamide inhibits gluconeogenesis in the tumor-influenced hepatocyte. J Surg Res (1993) 0.76
Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide. J Cell Physiol (1989) 0.76
Increased protein kinase C activity in low density eosinophils. J Immunol (1993) 0.76
Laminin responsiveness is associated with changes in fibroblast morphology, motility, and anchorage-independent growth: cell system for examining the interaction between laminin and EGF signaling pathways. J Cell Physiol (1995) 0.76
Science by screensaver. Inspired by the success of SETI@home, biologists launch a flurry of distributed-computing projects. Time (2000) 0.75
Distribution and ovarian control of progestin-metabolizing enzymes in various rat hypothalamic regions. J Steroid Biochem (1987) 0.75
Ontogeny of the epidermal growth factor receptor during development of the fetal bovine mesonephros and associated organs of the urogenital tract. Biol Reprod (1993) 0.75
Deconstructing dyslexia. Blame it on the written word. Time (2001) 0.75
Potent inhibition of the hypothalamic progesterone 5 alpha-reductase by a 5 alpha-dihydroprogesterone analog. J Biol Chem (1984) 0.75
Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors. Bioorg Med Chem Lett (1999) 0.75
Protein wizard. Time (2001) 0.75
Binding of epidermal growth factor and transforming growth factor-alpha in mammalian preimplantation embryos. Theriogenology (1994) 0.75
A high affinity inhibitor of pituitary progesterone 5 alpha-reductase. Endocrinology (1984) 0.75
Localization of epidermal growth factor receptors in first- and third-trimester human placentas. J Histochem Cytochem (1994) 0.75
Chronic exposure to lead acetate affects the development of protein kinase C activity and the distribution of the PKCgamma isozyme in the rat hippocampus. Neurotoxicology (1999) 0.75
Ovarian regulation of hypothalamic and pituitary progestin-metabolizing enzyme activities. Endocrinology (1981) 0.75
Autoimmune diseases. New ways to intervene when the body attacks itself. Time (2001) 0.75
Analysis of functional domains in the epidermal growth factor receptor using site-directed mutagenesis. Adv Exp Med Biol (1988) 0.75
Ah, the blue smell of it! Time (2001) 0.75